Glass Health

glass.health →

-89%

est. 2Y upside i

HealthcareSeed

Glass Health empowers doctors with an AI-powered platform that supports clinical decision-making.

Rank

#1725

Sector

HealthTech, AI in Healthcare

Est. Liquidity

~4Y

Data Quality

Data: Medium

Glass Health operates in the rapidly expanding AI in Healthcare market (projected ~40% CAGR), addressing critical needs like clinician burnout with its innovative Glass AI 2.0 platform.

Last updated: March 10, 2026

Bull (15%)+400%

Glass Health's Glass AI 2.0 achieves significant market traction, integrating successfully with major EHR systems (e.g., Epic, Cerner) through strategic partnerships. Its proprietary LLMs and physician-tuned knowledge base create a strong competitive advantage, leading to rapid adoption by large hospital systems and a substantial increase in institutional subscriptions. Revenue grows to $70M+ by 2028, justifying a $250M+ valuation (5x current estimated $50M).

Base (50%)+50%

Glass Health continues to grow steadily, securing a niche in clinical decision support for individual clinicians and smaller practices. It faces ongoing competition from incumbents and other startups, limiting its market share expansion. Revenue reaches $20M-$25M by 2028, leading to a modest valuation increase to $75M (1.5x current estimated $50M).

Bear (35%)-80%

Dominant incumbents like Microsoft (with Dragon Copilot) or major EHR vendors (Epic, Cerner) integrate superior or free AI clinical decision support tools, commoditizing Glass Health's offering. Regulatory hurdles or slower-than-expected clinician adoption further hinder growth. Revenue stagnates or declines, leading to a down round or acquisition at a significantly lower valuation ($10M-$15M), wiping out most common stock value given the preference stack.

Est. time to liquidity~4.0 years

Preference Stack Risk

moderate

Investors hold $5.5M in liquidation preferences. In an exit at or below the estimated $50M current valuation, common stock holders would receive value only after investors are paid back their $5.5M.

Dilution Risk

moderate

As a Series A company, Glass Health will likely raise additional funding rounds (Series B, C) before an exit, which will dilute the job seeker's equity percentage.

Secondary Liquidity

none

There is no active secondary market for shares in this early-stage, privately held company.

Questions to Ask at the Interview

Strategic questions based on Glass Health's data — designed to show you've done your homework.

  • 1

    “Given the strong presence of incumbents like Microsoft with Dragon Copilot and the integration capabilities of EHR giants like Epic and Cerner, how is Glass Health planning to differentiate and secure market share, particularly in enterprise healthcare systems?”

  • 2

    “With Glass Health's current revenue at ~$7M, what are the key milestones and growth strategies for scaling revenue significantly over the next 2-3 years, and what specific customer segments are being prioritized for expansion?”

  • 3

    “As a Series A company, what is the anticipated timeline for future funding rounds and a potential liquidity event, and how does the company plan to manage employee equity dilution through these stages?”

Community

Valuation Sentiment

Our model estimates -89% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.